Yıl: 2022 Cilt: 54 Sayı: 1 Sayfa Aralığı: 61 - 66 Metin Dili: İngilizce DOI: 10.5152/eurasianjmed.2022.21099 İndeks Tarihi: 24-06-2022

Neurological Evaluation of Geriatric Patients Being Treated for COVID-19

Öz:
Objective: The clinical presentation of coronavirus disease 2019 may be more severe in individuals with diagnoses such as neurodegenerative diseases and cerebrovascular disease, which may occur at an advanced age, among the underlying chronic neurological disorders. In this study, we analyzed the incidence of underlying neurological disorders, the clinical process, the effects on prognosis, duration of hospitalization, and clinical parameters such as mortality and the incidence of neurological manifestations that occurred in the study group after being infected and their relationship with the prognosis in patients hospitalized due to coronavirus disease 2019. Materials and Methods: This is a retrospective and single-centered study. Individuals aged 65 years and older whose diagnosis of coronavirus disease 2019 was confirmed and who were hospitalized for treatment were included in the study. Results: A total of 282 individuals were included in the study. Neurological manifestaitons were observed in 217 (77.0%) patients, and 131 (46.5%) patients had a neurological disorders in their medical history. Of the 58 patients in intensive care, 36 (12.8%) had a positive history of neurological disorders (P=.006). The incidences of diseases common in advanced age were 22 (7.8%) for dementia, 37 (13.1%) for cerebrovascular disease, and 4 (1.4%) for movement disorders. The most common symptom were myalgia in 67 (23.8%) patients. Conclusion: The clinical presentation was more severe and the risk of being treated in the intensive care unit was higher in individuals with a history of neurological disorders and neurological manifestations. Furthermore, patients who developed neurological manifestations had a greater risk of mortality and longer periods of hospitalization.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. [CrossRef]
  • 2. Mahase E. Covid-19: WHO declares pandemic because of “larming levels” of spread, severity, and inaction. BMJ. 2020;368:m1036. [CrossRef]
  • 3. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497- 506. [CrossRef]
  • 4. Gklinos P. Neurological indications of COVID-19: a review of what we know so far. J Neurol. 2020;267(9):2485-2489. [CrossRef]
  • 5. Kieseier BC, Lehmann HC, Meyer Zu Hörste G. Autoimmune diseases of the peripheral nervous system. Autoimmun Rev. 2012;11(3):191-195. [CrossRef]
  • 6. 6-World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance; 2020. Available at: https://apps.who.int/iris/handle/10665/330893. Accessed: 03.2020.
  • 7. Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. Am J Respir Crit Care Med. 2020;202(5):756-759. [CrossRef]
  • 8. Ng Kee Kwong KCNK, Mehta PR, Shukla G, Mehta AR. COVID-19, SARS and MERS: a neurological perspective. J Clin Neurosci. 2020;77:13- 16. [CrossRef]
  • 9. Desforges M, Le Coupanec A, Brison E, Meessen-Pinard M, Talbot PJ. Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Adv Exp Med Biol. 2014;807:75-96. [CrossRef]
  • 10. Desforges M, Le Coupanec A, Dubeau P, et al. Human Coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2019;12(1):14. [CrossRef]
  • 11. Guan WJ, Ni ZY, Zhong NS, et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med. 2020;382(18):1708-1720.
  • 12. Mao L, Jin H, Wang M, et al. Neurological manifestations of hospitalized patients with COVID19 in Wuhan, China: a retrospective case series study. JAMA Neurol. 2020;77(6):683-690. [CrossRef]
  • 13. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID −19 is higher compared to SARS coronavirus. J Travel Med. 2020;27(2):taaa021. [CrossRef]
  • 14. Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264-7275. [CrossRef]
  • 15. Tsai LK, Hsieh ST, Chang YC. Neurological Manions in severe acute respiratory syndrome. Acta Neurol Taiwan. 2005;14(3):113-119.
  • 16. Hung EC, Chim SS, Chan PK, et al. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem. 2003;49(12):2108-2109. [CrossRef]
  • 17. Welge-Lüssen A, Wolfensberger M. Olfactory disorders following upper respiratory tract infections. Adv Otorhinolaryngol. 2006;63:125-132. [CrossRef]
  • 18. Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host Microbe. 2013;13(4):379-393. [CrossRef]
  • 19. Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. 2018;12:386. [CrossRef]
  • 20. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a bacterial presentation of mildto-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251-2261. [CrossRef]
  • 21. Kotfis K, Williams Roberson S, Wilson JE, Dabrowski W, Pun BT, Ely EW. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care. 2020;24(1):176. [CrossRef]
  • 22. Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911-922. [CrossRef]
  • 23. Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268-2270. [CrossRef]
APA Adiguzel A, ÖZTÜRK Ü (2022). Neurological Evaluation of Geriatric Patients Being Treated for COVID-19. , 61 - 66. 10.5152/eurasianjmed.2022.21099
Chicago Adiguzel Ahmet,ÖZTÜRK Ünal Neurological Evaluation of Geriatric Patients Being Treated for COVID-19. (2022): 61 - 66. 10.5152/eurasianjmed.2022.21099
MLA Adiguzel Ahmet,ÖZTÜRK Ünal Neurological Evaluation of Geriatric Patients Being Treated for COVID-19. , 2022, ss.61 - 66. 10.5152/eurasianjmed.2022.21099
AMA Adiguzel A,ÖZTÜRK Ü Neurological Evaluation of Geriatric Patients Being Treated for COVID-19. . 2022; 61 - 66. 10.5152/eurasianjmed.2022.21099
Vancouver Adiguzel A,ÖZTÜRK Ü Neurological Evaluation of Geriatric Patients Being Treated for COVID-19. . 2022; 61 - 66. 10.5152/eurasianjmed.2022.21099
IEEE Adiguzel A,ÖZTÜRK Ü "Neurological Evaluation of Geriatric Patients Being Treated for COVID-19." , ss.61 - 66, 2022. 10.5152/eurasianjmed.2022.21099
ISNAD Adiguzel, Ahmet - ÖZTÜRK, Ünal. "Neurological Evaluation of Geriatric Patients Being Treated for COVID-19". (2022), 61-66. https://doi.org/10.5152/eurasianjmed.2022.21099
APA Adiguzel A, ÖZTÜRK Ü (2022). Neurological Evaluation of Geriatric Patients Being Treated for COVID-19. Eurasian Journal of Medicine, 54(1), 61 - 66. 10.5152/eurasianjmed.2022.21099
Chicago Adiguzel Ahmet,ÖZTÜRK Ünal Neurological Evaluation of Geriatric Patients Being Treated for COVID-19. Eurasian Journal of Medicine 54, no.1 (2022): 61 - 66. 10.5152/eurasianjmed.2022.21099
MLA Adiguzel Ahmet,ÖZTÜRK Ünal Neurological Evaluation of Geriatric Patients Being Treated for COVID-19. Eurasian Journal of Medicine, vol.54, no.1, 2022, ss.61 - 66. 10.5152/eurasianjmed.2022.21099
AMA Adiguzel A,ÖZTÜRK Ü Neurological Evaluation of Geriatric Patients Being Treated for COVID-19. Eurasian Journal of Medicine. 2022; 54(1): 61 - 66. 10.5152/eurasianjmed.2022.21099
Vancouver Adiguzel A,ÖZTÜRK Ü Neurological Evaluation of Geriatric Patients Being Treated for COVID-19. Eurasian Journal of Medicine. 2022; 54(1): 61 - 66. 10.5152/eurasianjmed.2022.21099
IEEE Adiguzel A,ÖZTÜRK Ü "Neurological Evaluation of Geriatric Patients Being Treated for COVID-19." Eurasian Journal of Medicine, 54, ss.61 - 66, 2022. 10.5152/eurasianjmed.2022.21099
ISNAD Adiguzel, Ahmet - ÖZTÜRK, Ünal. "Neurological Evaluation of Geriatric Patients Being Treated for COVID-19". Eurasian Journal of Medicine 54/1 (2022), 61-66. https://doi.org/10.5152/eurasianjmed.2022.21099